Highlights
A collection of news and information related to Rheumatoid Arthritis published by this site and its partners.
Displaying items 1-12 of 119
» View wsbt.com items only
1
2
3
4
5
6
7
8
9
10
•
Next >
-
Elan rejects Royalty's $6.4 billion raised offer
ReutersDUBLIN (Reuters) - Elan rejected Royalty Pharma's increased $6.4 billion bid on Thursday, shortly after the U.S. firm cut the acceptance bar for its latest offer to 50 percent plus one share. Royalty raised its hostile cash bid to $12.50 per share on...Tags: Elan Corporation Plc, GlaxoSmithKline PLC, Humira (drug), Theravance Incorporated, Multiple Sclerosis
-
In debate over 'biosimilars,' patient safety must come first
In 1988, I became extremely ill. I had many tests, saw many doctors and was given various medicines. Some caused allergic reactions. Through it all, I remained sick — and actually became worse. Eventually, I was diagnosed with autoimmune hepatitis,...Tags: Hepatitis, Food and Drug Administration, Health, Health and Medical Professionals, Rockville (Bethlehem, Pennsylvania)
-
Regeneron, Sanofi asthma drug seen as potential game changer
Reuters(Reuters) - A new type of asthma drug meant to attack the underlying causes of the respiratory disease slashed episodes by 87 percent in a mid-stage trial, making it a potential game changer for patients with moderate to severe disease, researchers said...Tags: Physical Conditions, Trials, Asthma, Respiratory Disease, Inflammation
-
Church work took her abroad on mission trips
Whether working in Central Florida or across the oceans in India or Romania, Barbara "Bobbie" Strickland loved working with children and teenagers through her church. She participated in dozens of mission trips to several countries through Eastpoint...Tags: Trips and Vacations, First Baptist Church of Orlando, Baptist, Arthritis, Skype
-
Belgium's Galapagos says on track to meet 2013 guidance
ReutersBRUSSELS, May 17 (Reuters) - Galapagos, the Belgian developer of drugs to fight autoimmune diseases such as lupus and rheumatoid arthritis, said it was on track to meet its full-year revenue guidance this year. The company, which raised almost 54 million...Tags: Lupus, Diseases and Illnesses, Crohn's Disease, Belgium
-
9-year-old Boyne City girl to be honored at Saturday Arthritis Walk in Traverse City
BOYNE CITY -- "My body!" cried Kami Chapp as her mother raced to get answers to her daughter's pain. Kami Chapp from Boyne City is a 9-year-old suffering from what many believe to be a "grown up" disease, but the Chapp family knows firsthand that...
Tags: Arthritis, Diseases and Illnesses, Arthritis Foundation, Physical Fitness and Exercise
-
It's Lyme season [Editorial]
With some exceptions, any illness can strike anyone at any time. One of the more dangerous to emerge in recent decades is Lyme disease. Harford County, as many of us know either first-hand or because of someone we know, is not immune from the tick-borne...Tags: Arthritis, Skin Rash, Lyme, U.S. Centers for Disease Control and Prevention, Allergies
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Pharmaceuticals, Chemical Industry, Humira (drug), Science and Technology, Science
-
REUTERS SUMMIT-Faster drug approvals a tonic for pharma industry
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) By Ben Hirschler NEW YORK, May 8 (Reuters) - A pickup in new drug approvals, the promise of faster regulatory decisions and more targeted medicines have...Tags: Food and Drug Administration, Lipitor (drug), Moody's Corporation, Breast Cancer, Bristol Myers Squibb Company
-
Big drugmakers think small with nanomedicine deals
Reuters* Nanomedicine promises greater precision and monitoring * Pfizer, Amgen, AstraZeneca among firms placing bets * Early-stage research but scientists see momentum building By Ben Hirschler LONDON, May 3 (Reuters) - Is nanomedicine the next big thing? A...Tags: Nanotechnology, Kaposi's sarcoma, Massachusetts Institute of Technology, Technology, Tel Aviv (Israel)
-
Humira sales propel AbbVie in 1Q
Tribune staff reporterIn its first quarter as an independent, publicly traded company, AbbVie Inc. said net income rose 9.6 percent, to $968 million, or 60 cents a share, from $883 million, or 56 cents a share, a year earlier when the company was still a part of Abbott...Tags: Crohn's Disease, Science and Technology, Psoriasis, Companies and Corporations, Hepatitis
-
CORRECTED-Court stops EU regulator releasing drug company data
Reuters(Corrects to make clear competitor sought information on Intermune drug, paragraph 8) By Ben Hirschler LONDON, April 30 (Reuters) - Europe's medicines regulator has been stopped from releasing clinical trial data about drugs made by AbbVie and...Tags: Trials, Drugs and Medicines, Humira (drug), European Union, Litigation
May 23, 2013
|Story| Reuters
May 22, 2013
|Story| Baltimore Sun
May 21, 2013
|Story| Reuters
May 17, 2013
|Story| Orlando Sentinel
May 16, 2013
|Story| Reuters
May 16, 2013
|Story| Petoskey News
May 14, 2013
|Story| Baltimore Sun
May 10, 2013
|Story| Reuters
May 8, 2013
|Story| Reuters
May 3, 2013
|Story| Reuters
Apr 26, 2013
|Story| Chicago Tribune
Apr 30, 2013
|Story| Reuters
Original site for Rheumatoid Arthritis topic gallery.
